Mortality associated with HIV-1, HIV-2, and HTLV-I single and dual infections in a middle-aged and older population in Guinea-Bissau.

Birgitta Holmgren, Zacarias da Silva, Pernille Vastrup, Olav Larsen, Sören Andersson, Henrik Ravn, Peter Aaby
Author Information
  1. Birgitta Holmgren: Bandim Health Project, Bissau, INDEPTH Network, Guinea-Bissau. Birgitta_G.Holmgren@med.lu.se

Abstract

BACKGROUND: In Guinea-Bissau HIV-1, HIV-2, and HTLV-I are prevalent in the general population. The natural history of HIV/HTLV-I single and dual infections has not been fully elucidated in this population. Previous studies have shown that combinations of these infections are more common in older women than in men. The present study compares mortality associated with HIV-1, HIV-2, and HTLV-I single and dual infections in individuals over 35 years of age within an urban community-based cohort in Guinea-Bissau.
RESULTS: A total of 2,839 and 1,075 individuals were included in the HIV and HTLV-I mortality analyses respectively. Compared with HIV-negative individuals, adjusted mortality rate ratios (MRRs) were 4.9 (95% confidence interval (CI): 2.3, 10.4) for HIV-1, 1.8 (95%CI: 1.5, 2.3) for HIV-2, and 5.9 (2.4, 14.3) for HIV-1/HIV-2 dual infections. MRR for HTLV-I-positive compared with HTLV-I-negative individuals was 1.7 (1.1, 2.7). Excluding all HIV-positive individuals from the analysis, the HTLV-I MRR was 2.3 (1.3, 3.8). The MRR of HTLV-I/HIV-2 dually infected individuals was 1.7 (0.7, 4.3), compared with HIV/HTLV-I-negative individuals. No statistically significant differences were found in retrovirus-associated mortality between men and women.
CONCLUSION: HIV-1-associated excess mortality was low compared with community studies from other parts of Africa, presumably because this population was older and the introduction of HIV-1 into the community recent. HIV-2 and HTLV-I-associated mortality was 2-fold higher than the mortality in uninfected individuals. We found no significant differences between the mortality risk for HIV-2 and HTLV-I single infection, respectively, and HIV-2/HTLV-I dual infection. The higher prevalence of retroviral dual infections in older women is not explained by differential retrovirus-associated mortality for men and women.

References

  1. Nat Med. 1996 Oct;2(10):1084-9 [PMID: 8837605]
  2. Lancet. 1986 May 3;1(8488):1031-2 [PMID: 2871307]
  3. J Acquir Immune Defic Syndr (1988). 1990;3(11):1096-101 [PMID: 2213510]
  4. Int J Epidemiol. 2004 Feb;33(1):163-72 [PMID: 15075165]
  5. J Acquir Immune Defic Syndr. 2000 Oct 1;25(2):157-63 [PMID: 11103046]
  6. Scand J Infect Dis. 1999;31(5):459-66 [PMID: 10576124]
  7. Genitourin Med. 1995 Aug;71(4):212-5 [PMID: 7590710]
  8. AIDS. 1998 Sep 10;12(13):1707-14 [PMID: 9764792]
  9. BMJ. 1997 Sep 27;315(7111):767-71 [PMID: 9345167]
  10. BMJ. 1992 Mar 28;304(6830):809-13 [PMID: 1392708]
  11. AIDS. 1997 May;11(6):705-12 [PMID: 9143601]
  12. J Acquir Immune Defic Syndr. 2002 Jul 1;30(3):342-50 [PMID: 12131572]
  13. AIDS. 2001 Nov 23;15(17):2303-10 [PMID: 11698704]
  14. Int J Epidemiol. 1996 Oct;25(5):1090-7 [PMID: 8921499]
  15. J Acquir Immune Defic Syndr (1988). 1993 Aug;6(8):941-8 [PMID: 8315578]
  16. AIDS. 1996 Nov;10(13):1585-90 [PMID: 8931796]
  17. Int J Cancer. 1998 May 4;76(3):293-8 [PMID: 9579561]
  18. Scand J Infect Dis. 2000;32(2):169-75 [PMID: 10826903]
  19. FEMS Immunol Med Microbiol. 2003 Aug 18;38(1):13-22 [PMID: 12900050]
  20. AIDS. 1993 Aug;7(8):1119-22 [PMID: 8397950]
  21. Lancet. 1989 Apr 15;1(8642):827-31 [PMID: 2564911]
  22. J Infect Dis. 2000 Sep;182(3):708-15 [PMID: 10950763]
  23. Scand J Infect Dis. 1998;30(4):323-9 [PMID: 9817509]
  24. Virology. 1999 Sep 30;262(2):312-20 [PMID: 10502510]
  25. AIDS Res Hum Retroviruses. 1999 Jan 1;15(1):3-9 [PMID: 10024047]
  26. Lancet. 1985 Aug 24;2(8452):407-10 [PMID: 2863442]
  27. AIDS Res Hum Retroviruses. 1998 Jun 10;14(9):815-9 [PMID: 9643383]
  28. AIDS Res Hum Retroviruses. 2000 Sep 20;16(14):1371-8 [PMID: 11018856]
  29. AIDS. 1994 Dec;8(12):1707-13 [PMID: 7888120]
  30. AIDS. 1995 Oct;9(10):1185-91 [PMID: 8519456]
  31. J Acquir Immune Defic Syndr. 2000 Feb 1;23(2):194-202 [PMID: 10737435]
  32. J Infect Dis. 2003 Dec 1;188(11):1648-51 [PMID: 14639534]
  33. AIDS. 2002 May 3;16(7):1059-66 [PMID: 11953473]
  34. J Infect Dis. 1999 Jan;179(1):68-73 [PMID: 9841824]
  35. AIDS. 1997 May;11(6):801-7 [PMID: 9143613]
  36. AIDS. 2004 Aug 20;18(12):1637-43 [PMID: 15280774]
  37. Nature. 1981 Nov 19;294(5838):268-71 [PMID: 6272125]
  38. Int J Cancer. 1989 Feb 15;43(2):250-3 [PMID: 2917802]
  39. AIDS. 1990 May;4(5):443-8 [PMID: 2164821]
  40. Scand J Infect Dis. 2001;33(6):450-6 [PMID: 11450865]
  41. Virology. 1998 May 25;245(1):1-10 [PMID: 9614862]
  42. Lancet. 1987 May 9;1(8541):1085-6 [PMID: 2883415]
  43. AIDS. 2003 Jan 24;17(2):241-53 [PMID: 12545085]
  44. Lancet. 1994 Apr 23;343(8904):1021-3 [PMID: 7909054]
  45. AIDS. 1994 Jan;8(1):87-92 [PMID: 8011241]
  46. Jpn J Cancer Res. 1998 Aug;89(8):797-805 [PMID: 9765614]
  47. AIDS. 1994 Jul;8(7):977-82 [PMID: 7946109]
  48. AIDS. 2002 Jul 26;16(11):1545-50 [PMID: 12131193]
  49. Lancet. 1997 Mar 29;349(9056):911-4 [PMID: 9093252]
  50. Cancer Causes Control. 2003 Nov;14(9):889-96 [PMID: 14682446]
  51. AIDS. 1992 Aug;6(8):803-7 [PMID: 1329848]
  52. J Acquir Immune Defic Syndr. 2005 Dec 15;40(5):625-8 [PMID: 16284541]
  53. Jpn J Cancer Res. 1994 Mar;85(3):231-7 [PMID: 8188520]
  54. J Infect Dis. 1993 Jan;167(1):57-65 [PMID: 8418183]

MeSH Term

Adult
Cohort Studies
Comorbidity
Female
Guinea-Bissau
HIV Infections
HIV-1
HIV-2
HTLV-I Infections
Human T-lymphotropic virus 1
Humans
Male
Middle Aged
Risk Factors
Urban Population

Word Cloud

Created with Highcharts 10.0.0mortalityindividuals13HIV-2HTLV-Idualinfections2HIV-1populationsingleolderwomen47Guinea-BissaumenMRRcomparedstudiesassociatedrespectively985significantdifferencesfoundretrovirus-associatedcommunityhigherinfectionBACKGROUND:prevalentgeneralnaturalhistoryHIV/HTLV-IfullyelucidatedPreviousshowncombinationscommonpresentstudycompares35yearsagewithinurbancommunity-basedcohortRESULTS:total839075includedHIVanalysesComparedHIV-negativeadjustedrateratiosMRRs95%confidenceintervalCI:1095%CI:14HIV-1/HIV-2HTLV-I-positiveHTLV-I-negativeExcludingHIV-positiveanalysisHTLV-I/HIV-2duallyinfected0HIV/HTLV-I-negativestatisticallyCONCLUSION:HIV-1-associatedexcesslowpartsAfricapresumablyintroductionrecentHTLV-I-associated2-folduninfectedriskHIV-2/HTLV-IprevalenceretroviralexplaineddifferentialMortalitymiddle-aged

Similar Articles

Cited By